2021
DOI: 10.3389/fcell.2021.734749
|View full text |Cite
|
Sign up to set email alerts
|

TAK1: A Molecular Link Between Liver Inflammation, Fibrosis, Steatosis, and Carcinogenesis

Abstract: Chronic insult and persistent injury can cause liver inflammation, fibrosis, and carcinogenesis; it can also be associated with metabolic disorders. Identification of critical molecules that link the process of inflammation and carcinogenesis will provide prospective therapeutic targets for liver diseases. Rapid advancements in gene engineering technology have allowed the elucidation of the underlying mechanism of transformation, from inflammation and metabolic disorders to carcinogenesis. Transforming growth … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
7
0

Year Published

2022
2022
2023
2023

Publication Types

Select...
6
2

Relationship

1
7

Authors

Journals

citations
Cited by 16 publications
(7 citation statements)
references
References 115 publications
(164 reference statements)
0
7
0
Order By: Relevance
“…For example, we noted significantly increased phosphorylation of JNK target site Ser350 (Table S8), which suppresses signalling IRS2 function (Solinas et al, 2006). Moreover, we observed activating phosphorylation on AMPK1alpha (Thr183), which is a target of MAPK3K/TAK1 (Wang et al, 2021) (Table S8), and a simultaneous increase on the activating AMPK target site on TSC2 – which results in inhibition of mTOR signalling downstream of Insulin (Inoki et al, 2003).…”
Section: Resultsmentioning
confidence: 90%
“…For example, we noted significantly increased phosphorylation of JNK target site Ser350 (Table S8), which suppresses signalling IRS2 function (Solinas et al, 2006). Moreover, we observed activating phosphorylation on AMPK1alpha (Thr183), which is a target of MAPK3K/TAK1 (Wang et al, 2021) (Table S8), and a simultaneous increase on the activating AMPK target site on TSC2 – which results in inhibition of mTOR signalling downstream of Insulin (Inoki et al, 2003).…”
Section: Resultsmentioning
confidence: 90%
“…TAK1 is a key molecule in the regulation of in ammation and cell death and plays a critical role in regulating cell survival, differentiation and apoptosis. TAK1 activates NF-κB, promotes transcription of downstream anti-apoptotic proteins and promotes cell growth and proliferation (23). At the same time, inhibition or deletion of TAK1 can initiate RIPK1-mediated apoptosis or RIPK1-RIPK3-mediated necroptosis, promoting programmed cell death in a variety of cells.…”
Section: Discussionmentioning
confidence: 99%
“…Another genetically modified liver fibrosis mouse model is a mouse with hepatocyte deletion of the TGF-β–activated kinase 1, a mitogen-activated protein kinase kinase kinase activated by interleukin 1, TGF-β, and Toll-like receptor ligands. 90 Hepatocyte-specific TGF-β–activated kinase 1 -/- mice spontaneously develop pericellular and periportal liver fibrosis from 1 month of age, followed by HCC formation at 6 months of age. 91 …”
Section: In Vivo Models Of Experimental Liver Fibrosismentioning
confidence: 99%